2011
11. Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells.
Sanchez-Antequera Y, Mykhaylyk O, van Til NP, Cengizeroglu A, de Jong JH, Huston MW, Anton M, Johnston IC, Pojda Z, Wagemaker G, Plank C
Blood. 2011 Apr 21.
2010
12. Liposomal magnetofection.
Mykhaylyk O, Sánchez-Antequera Y, Vlaskou D, Hammerschmid E, Anton M, Zelphati O, Plank C
Methods Mol Biol. 2010 .
13. Bioluminescence imaging allows measuring CD8 T cell function in the liver.
Stabenow D, Frings M, Trück C, Gärtner K, Förster I, Kurts C, Tüting T, Odenthal M, Dienes HP, Cederbrant K, Protzer U, Knolle PA
Hepatology. 2010 Apr .
2009
14. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.
Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F
Hepatology. 2009 Sep .
2007
17. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, Hauser S, Flechsig C, Krell HW, Antolovic D, Brew K, Nagase H, Stangl M, von Weyhern CW, Brücher BL, Brand K, Coussens LM, Edwards DR, Krüger A
Cancer Res. 2007 Sep 15.
2002
18. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo.
Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Krüger A, Gänsbacher B, Plank C
Gene Ther. 2002 Jan .
